← Back to Search

DeTAP Study App and Home Devices for Atrial Fibrillation (DeTAP Trial)

N/A
Waitlist Available
Led By Rajesh Dash, MD PhD
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

DeTAP Trial Summary

The purpose of this study is to validate an approach to decentralize, or virtualize, the clinical trial experience for enrolled subjects, through the coordinated use of multiple digital health and telehealth technologies. The study aims to validate the feasibility, acceptability and best practices of coordinating/integrating several individual digital health technologies to achieve execution of high compliance, cost-efficient, and scientifically sound clinical trials.

DeTAP Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Effectiveness of notifications
Engagement with study protocol

DeTAP Trial Design

1Treatment groups
Experimental Treatment
Group I: DeTAP Study App and Home DevicesExperimental Treatment1 Intervention
Monitoring of OAC administration, OAC adherence, and clinical status through combined decentralized technologies
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Use of DeTAP App and Home Devices
2020
N/A
~110

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,395 Previous Clinical Trials
17,341,493 Total Patients Enrolled
18 Trials studying Atrial Fibrillation
425,543 Patients Enrolled for Atrial Fibrillation
Rajesh Dash, MD PhDPrincipal InvestigatorStanford University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Decentralized Trial in Atrial Fibrillation Patients
Rajesh Dash, MD PHD 2020. "Decentralized Trial in Atrial Fibrillation Patients". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04471623.
~22 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top